Eikon Therapeutics, Inc. Common Stock· EIKN

Is the company consistently growing revenue, EBIT, EBITDA, and net income?

Are per-share metrics (revenue, net income, book value) trending upward?

Are gross, operating, EBITDA, and net margins improving?

Is the company using its assets efficiently and optimizing cash conversion?

Are ROA, ROE, ROIC, and ROCE at or above target levels?

Is the company generating strong operating and free cash flow?

Does the company maintain adequate liquidity and efficient working capital?

Is debt at sustainable levels and well covered by earnings?

Are valuation multiples reasonable compared to history and peers?

Are dividends and shareholder returns sustainable and attractive?